Literature DB >> 16788247

Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease.

József Balla1, Mária Tünde Magyar, Dániel Bereczki, Attila Valikovics, Emöke Nagy, Erika Barna, András Pál, György Balla, László Csiba, György Blaskó.   

Abstract

OBJECTIVE: Soluble CD40 ligand (sCD40L) has been suggested as a key mediator between inflammation and atherosclerosis, and the CD40-CD40L interaction has a role in atherosclerotic lesion progression. We evaluated if platelet released serum sCD40L and sCD40 levels differ between patients with early onset occlusive carotid artery disease and age-matched controls.
METHODS: sCD40L and sCD40 levels were measured in serum samples of 60 patients with occlusive carotid artery disease and 30 age-matched controls using ELISA. Degree of stenosis of the internal carotid artery (ICA), and intima-media thickness (IMT) in the common carotid artery were measured by high resolution ultrasound. Values are given as mean +/- SD.
RESULTS: Mean age was 50.9 +/- 3.5 and 50.1 +/- 3.5 years in the patient and control groups. IMT was significantly thicker in patients than in controls (0.89 +/- 0.14 vs. 0.78 +/-0.12 mm, p=0.0003). Serum levels of sCD40L were significantly higher (6.9 +/- 5 vs. 4.5 +/- 3.0 ng/mL, p=0.038) in patients, whereas sCD40 did not differ significantly between patients and controls (85 +/- 56.9 vs. 79.3 +/- 18.7 pg/mL, p=0.34). IMT did not correlate with sCD40L or sCD40 levels (R=-0.03, p=0.77; and R=0.109, p=0.308, respectively).
CONCLUSIONS: sCD40L but not sCD40 levels are significantly higher in patients with occlusive carotid artery disease. Platelet derived sCD40L may be a key mediator among inflammation, thrombosis and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788247      PMCID: PMC3851067          DOI: 10.1155/2006/427174

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  5 in total

1.  Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease.

Authors:  Rashi Chaturvedi; Mili Gupta; Ashish Jain; Tarun Das; Savita Prashar
Journal:  Clin Oral Investig       Date:  2014-03-05       Impact factor: 3.573

2.  Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes: Meta-Analyses and Mendelian Randomization Analyses.

Authors:  Lars Lind; Bruna Gigante; Yan Borné; Tobias Feldreich; Jerzy Leppert; Pär Hedberg; Carl Johan Östgren; Fredrik H Nyström; Johan Sundström; Johan Ärnlöv; Damiano Baldassarre; Elena Tremoli; Fabrizio Veglia; Anders Hamsten; Christopher J O'Donnell; Nora Franceschini; Marju Orho-Melander; Jan Nilsson; Olle Melander; Gunnar Engström; Anders Mälarstig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-04       Impact factor: 8.311

3.  Influence of angiotensin-converting enzyme inhibition on reversibility of alterations in arterial wall and cognitive performance associated with early hypertension: A follow-up study.

Authors:  Enikő Csikai; Mónika Andrejkovics; Bernadett Balajthy-Hidegh; Gergely Hofgárt; László Kardos; Ágnes Diószegi; Róbert Rostás; Katalin Réka Czuriga-Kovács; Éva Csongrádi; László Csiba
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness.

Authors:  Huocheng Liao; Zhiming Li; Dongdan Zheng; Jianping Liu; Yan Liu; Chun Xiao; Hongguang Wang
Journal:  Lipids Health Dis       Date:  2014-07-29       Impact factor: 3.876

5.  Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors.

Authors:  Agata Stanek; Armand Cholewka; Tomasz Wielkoszyński; Ewa Romuk; Karolina Sieroń; Aleksander Sieroń
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.